Jacobio Pharma Announces 2023 Annual Results
BEIJING, SHANGHAI and BOSTON, March 29, 2024 Jacobio/PRNewswire/ — Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was RMB 1.2 billion. Jacobio Pharma also announced its […]